CLINICAL_TRIALS
trial_result
· 2019-02-19
Clinical Trial Update: Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors [Phase 1, Phase 2]
Summary
This clinical trial update describes salvage chemotherapy regimens being studied for poor-prognosis germ cell tumors in Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Germ Cell Tumor | Phase 1, Phase 2 | Status: UNKNOWN